Single, Shared System Risk Evaluation and Mitigation Strategies: Opportunities and Challenges On-Demand Webinar

Quantity

Back to Results

Recorded May 14, 2019 | On-Demand Webinar

The FDA recently released two draft guidance documents, “Development of a Shared System REMS” and “Waivers of the Single, Shared System REMS Requirement.” These guidances establish the conditions when a Single, Shared System Risk Evaluation and Mitigation Strategy (SSS REMS) is required or may be beneficial to sponsors, and how to request a waiver from a SSS REMS. While the FDA may require generic drug manufacturers to share an SSS REMS with the listed drug manufacturer in order to manage and mitigate the drug’s potential safety risks, SSS REMS are very difficult, and in some cases impossible, to achieve and can be a potential reason for delayed generic drug entry to the market.

In this 90-minute webinar, experts will discuss the impact of these guidances on both the medical products community and on public health and access. The webinar will also cover issues companies face in developing an SSS REMS, and the impact the CREATES Act, if passed by Congress, would have on addressing REMS concerns.

IE and Edge users: Microsoft Internet Explorer (IE) and Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you in your purchase.

Assign Members :

Members Assigned | Assign all contacts Unassign all contacts

Add New Contact

Assign	Full Name	Account Name	Email	Role

Total Records - Showing Page

Add New Contact

Discounts and special pricing for additional items will be applied once you add the item to your cart.